Email updates

Keep up to date with the latest news and content from BMC Neurology and BioMed Central.

This article is part of the supplement: Proceedings of the 2009 Drug Discovery for Neurodegeneration Conference

Open Access Highly Accessed Email this article to a friend

The basics of preclinical drug development for neurodegenerative disease indications

Karen L Steinmetz and Edward G Spack

BMC Neurology 2009, 9(Suppl 1):S2  doi:10.1186/1471-2377-9-S1-S2

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Neurology's emails?